• LAST PRICE
    5.3800
  • TODAY'S CHANGE (%)
    Trending Down-0.4100 (-7.0812%)
  • Bid / Lots
    5.3800/ 2
  • Ask / Lots
    5.6400/ 3
  • Open / Previous Close
    5.7500 / 5.7900
  • Day Range
    Low 5.3700
    High 5.8300
  • 52 Week Range
    Low 4.3050
    High 19.3400
  • Volume
    1,786,158
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 5.79
TimeVolumeVERV
09:32 ET221025.79
09:33 ET128405.72
09:35 ET8205.681
09:37 ET58785.6804
09:39 ET28015.6787
09:42 ET148065.65
09:44 ET26145.64
09:46 ET29385.61
09:48 ET57795.5988
09:50 ET27245.58
09:51 ET21805.59
09:53 ET27885.55
09:55 ET11505.56
09:57 ET458295.54
10:00 ET104495.575
10:02 ET57135.55
10:04 ET122705.56
10:06 ET43215.56
10:08 ET40805.53
10:09 ET37065.5563
10:11 ET52275.55
10:13 ET23165.585
10:15 ET36605.63
10:18 ET296505.65
10:20 ET45695.7
10:22 ET38655.715
10:24 ET30555.73
10:26 ET33605.71
10:27 ET39505.71
10:29 ET22095.71
10:31 ET88945.6839
10:33 ET31485.66
10:36 ET106065.73
10:38 ET49165.76
10:40 ET37705.74
10:42 ET63105.765
10:44 ET96475.77
10:45 ET12005.775
10:47 ET27005.775
10:49 ET18615.78
10:51 ET7235.79
10:54 ET12845.81
10:56 ET31065.78
10:58 ET4005.79
11:00 ET75005.83
11:02 ET8005.82
11:03 ET7005.8
11:05 ET6005.79
11:07 ET13105.8
11:09 ET9725.803
11:12 ET30005.81
11:14 ET5115.81
11:16 ET9445.82
11:18 ET22185.81
11:20 ET4005.7989
11:21 ET32005.795
11:23 ET13765.785
11:25 ET67845.775
11:27 ET10905.76
11:30 ET7005.76
11:32 ET7005.76
11:34 ET12295.7593
11:36 ET51425.75
11:38 ET12035.75
11:39 ET5005.74
11:41 ET1005.74
11:43 ET7655.725
11:45 ET12455.715
11:48 ET19005.735
11:50 ET3175.72
11:52 ET5005.725
11:54 ET4005.72
11:56 ET7235.71
11:57 ET6005.725
11:59 ET27285.73
12:01 ET6955.73
12:03 ET1005.735
12:06 ET7125.74
12:08 ET1005.73
12:10 ET5475.74
12:12 ET1535.7401
12:14 ET3835.735
12:15 ET4005.7237
12:17 ET4005.7201
12:19 ET35285.715
12:21 ET1005.715
12:24 ET3005.71
12:26 ET8255.725
12:28 ET27375.72
12:30 ET5005.735
12:32 ET8325.73
12:33 ET5005.72
12:35 ET2065.715
12:37 ET83235.705
12:39 ET12755.69
12:42 ET31315.68
12:44 ET5655.68
12:46 ET4185.65
12:48 ET5595.63
12:50 ET18485.64
12:53 ET6005.64
12:55 ET23545.66
12:57 ET3005.645
01:00 ET6005.65
01:02 ET2005.65
01:04 ET8665.65
01:08 ET3095.65
01:09 ET5005.65
01:11 ET9925.65
01:13 ET15175.645
01:15 ET2005.6488
01:18 ET6745.64
01:20 ET11275.6492
01:22 ET1075.65
01:24 ET23305.6501
01:26 ET2505.65
01:27 ET50705.67
01:29 ET11805.68
01:31 ET4585.665
01:33 ET4005.67
01:36 ET3095.675
01:38 ET3005.675
01:42 ET30445.67
01:44 ET7275.67
01:45 ET97515.67
01:47 ET34005.67
01:49 ET6035.675
01:51 ET31225.695
01:54 ET1605.695
01:56 ET39955.7
01:58 ET13815.705
02:00 ET42975.7296
02:02 ET66715.7601
02:03 ET78005.75
02:05 ET17765.745
02:07 ET65945.74
02:09 ET84205.74
02:12 ET3825.74
02:14 ET1005.74
02:16 ET2005.74
02:18 ET661375.69
02:20 ET10425.6706
02:21 ET54065.66
02:23 ET43135.6674
02:25 ET8155.67
02:27 ET11055.65
02:30 ET12775.66
02:34 ET18865.66
02:36 ET9705.65
02:38 ET38945.66
02:39 ET17685.68
02:41 ET7485.675
02:43 ET4005.67
02:45 ET5165.675
02:48 ET3005.67
02:50 ET12745.67
02:52 ET7165.685
02:54 ET6635.69
02:56 ET1005.6901
02:57 ET13415.68
02:59 ET3005.68
03:01 ET24325.66
03:03 ET7665.65
03:06 ET41885.615
03:08 ET72875.575
03:10 ET19465.6
03:12 ET17685.605
03:14 ET11505.6
03:15 ET1005.6
03:17 ET43545.635
03:19 ET15395.64
03:21 ET12815.62
03:24 ET10715.6
03:26 ET26255.62
03:28 ET8615.6
03:30 ET37515.625
03:32 ET35405.6
03:33 ET17455.575
03:35 ET109445.57
03:37 ET128595.61
03:39 ET60475.605
03:42 ET263345.615
03:44 ET196165.545
03:46 ET10005.525
03:48 ET36835.515
03:50 ET369135.475
03:51 ET142245.475
03:53 ET108805.445
03:55 ET263265.43
03:57 ET298855.415
04:00 ET3441695.38
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVERV
Verve Therapeutics Inc
490.2M
-2.2x
---
United StatesPRQR
ProQR Therapeutics NV
419.4M
-14.1x
---
United StatesSSII
SS Innovations International Inc
512.2M
-20.1x
---
United StatesTSHA
Taysha Gene Therapies Inc
452.9M
-2.5x
---
United StatesMGTX
MeiraGTx Holdings PLC
543.4M
-4.4x
---
United StatesQTTB
Q32 Bio Inc
483.9M
-4.8x
---
As of 2024-11-15

Company Information

Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Company’s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). VERVE-101 and VERVE-102 are designed to permanently turn off the PCSK9 gene in the liver and are being developed initially for heterozygous familial hypercholesterolemia (HeFH). VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for homozygous familial hypercholesterolemia (HoFH) and for refractory hypercholesterolemia where patients still have high LDL-C despite treatment with maximally tolerated standard of care therapies.

Contact Information

Headquarters
201 Brookline Avenue, Suite 601BOSTON, MA, United States 02215
Phone
978-501-3026
Fax
302-655-5049

Executives

Independent Chairman of the Board
Burt Adelman
President, Chief Operating Officer, General Counsel
Andrew Ashe
Chief Executive Officer, Director
Sekar Kathiresan
Chief Financial Officer
Allison Dorval
Chief Administrative Officer
Joan Nickerson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$490.2M
Revenue (TTM)
$24.4M
Shares Outstanding
84.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.74
EPS
$-2.46
Book Value
$7.31
P/E Ratio
-2.2x
Price/Sales (TTM)
20.1
Price/Cash Flow (TTM)
---
Operating Margin
-928.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.